| David Michael Lareau, MD | |
|
455 Tollgate Rd, Warwick, RI 02886-2759 | |
| (401) 737-7000 | |
| Not Available |
| Full Name | David Michael Lareau |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 33 Years |
| Location | 455 Tollgate Rd, Warwick, Rhode Island |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811092075 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 01054862 (Indiana) | Secondary |
| 207L00000X | Anesthesiology | MD08118 (Rhode Island) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Our Lady Of Fatima Hospital | North providence, RI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Narragansett Bay Anesthesia Llc | 5991774929 | 100 |
News Archive
The association between obesity and gastrointestinal-related cancers and coronary artery disease; the link between an overweight or obese body mass index and the severity of Crohn's disease; and whether inflammatory bowel disease is an independent risk factor for coronary artery disease, were among the highlights of new research that was presented this week at the American College of Gastroenterology's (ACG) 75th Annual Scientific meeting in San Antonio.
Many tumors possess mechanisms to avoid destruction by the immune system. For instance, they misuse the natural "brakes" in the immune defense mechanism, which normally prevent an excessive immune response. Researchers at the University of Bonn have now been able to take off one of these brakes.
Beta-blocker therapy in patients with heart failure is well tolerated and associated with fewer overall withdrawals and less heart failure deterioration than placebo, according to a new article in the Archives of Internal Medicine, one of the JAMA/Archives journals.
In this post in the Results for Development Institute's "Center for Global Health R&D Policy Assessment" blog, Hassan Masum, a consultant at the institute, interviews Alph Bingham, co-founder of Innocentive, an online platform for crowdsourcing technical solutions, about issues surrounding collaborative research and development (R&D) to advance health technologies.
TSO3 Inc., an innovator in sterilization technology for medical devices in healthcare settings, today announced that the Company is having productive discussions with US regulators, including a very recent face-to-face meeting. The Company is actively engaged in the changing US regulatory process intended to lead to the refilling for 510(k) clearance on its new generation sterilizer.
› Verified 9 days ago
| Entity Name | Narragansett Bay Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861445728 PECOS PAC ID: 5991774929 Enrollment ID: O20040928000003 |
News Archive
The association between obesity and gastrointestinal-related cancers and coronary artery disease; the link between an overweight or obese body mass index and the severity of Crohn's disease; and whether inflammatory bowel disease is an independent risk factor for coronary artery disease, were among the highlights of new research that was presented this week at the American College of Gastroenterology's (ACG) 75th Annual Scientific meeting in San Antonio.
Many tumors possess mechanisms to avoid destruction by the immune system. For instance, they misuse the natural "brakes" in the immune defense mechanism, which normally prevent an excessive immune response. Researchers at the University of Bonn have now been able to take off one of these brakes.
Beta-blocker therapy in patients with heart failure is well tolerated and associated with fewer overall withdrawals and less heart failure deterioration than placebo, according to a new article in the Archives of Internal Medicine, one of the JAMA/Archives journals.
In this post in the Results for Development Institute's "Center for Global Health R&D Policy Assessment" blog, Hassan Masum, a consultant at the institute, interviews Alph Bingham, co-founder of Innocentive, an online platform for crowdsourcing technical solutions, about issues surrounding collaborative research and development (R&D) to advance health technologies.
TSO3 Inc., an innovator in sterilization technology for medical devices in healthcare settings, today announced that the Company is having productive discussions with US regulators, including a very recent face-to-face meeting. The Company is actively engaged in the changing US regulatory process intended to lead to the refilling for 510(k) clearance on its new generation sterilizer.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Michael Lareau, MD 690 Canton St, Suite 325, Westwood, MA 02090-2321 Ph: (781) 407-7713 | David Michael Lareau, MD 455 Tollgate Rd, Warwick, RI 02886-2759 Ph: (401) 737-7000 |
News Archive
The association between obesity and gastrointestinal-related cancers and coronary artery disease; the link between an overweight or obese body mass index and the severity of Crohn's disease; and whether inflammatory bowel disease is an independent risk factor for coronary artery disease, were among the highlights of new research that was presented this week at the American College of Gastroenterology's (ACG) 75th Annual Scientific meeting in San Antonio.
Many tumors possess mechanisms to avoid destruction by the immune system. For instance, they misuse the natural "brakes" in the immune defense mechanism, which normally prevent an excessive immune response. Researchers at the University of Bonn have now been able to take off one of these brakes.
Beta-blocker therapy in patients with heart failure is well tolerated and associated with fewer overall withdrawals and less heart failure deterioration than placebo, according to a new article in the Archives of Internal Medicine, one of the JAMA/Archives journals.
In this post in the Results for Development Institute's "Center for Global Health R&D Policy Assessment" blog, Hassan Masum, a consultant at the institute, interviews Alph Bingham, co-founder of Innocentive, an online platform for crowdsourcing technical solutions, about issues surrounding collaborative research and development (R&D) to advance health technologies.
TSO3 Inc., an innovator in sterilization technology for medical devices in healthcare settings, today announced that the Company is having productive discussions with US regulators, including a very recent face-to-face meeting. The Company is actively engaged in the changing US regulatory process intended to lead to the refilling for 510(k) clearance on its new generation sterilizer.
› Verified 9 days ago
Regis P Burlas, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1131 Warwick Ave, Warwick, RI 02888 Phone: 401-287-4440 Fax: 401-461-4791 | |
Dr. Richard David Langfield, D.O. Anesthesiology Medicare: May Accept Medicare Assignments Practice Location: 455 Toll Gate Rd, Warwick, RI 02886 Phone: 401-737-7010 | |
Dr. Jean Paul Gottret, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 455 Toll Gate Rd, Warwick, RI 02886 Phone: 215-720-6095 | |
Dr. Afreen Siddiqui, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 935 Jefferson Blvd, Suite 1002, Warwick, RI 02886 Phone: 401-490-7530 Fax: 401-490-7533 | |
Dr. Manuel E Saborio, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 125 Squantum Dr, Warwick, RI 02888 Phone: 401-463-8537 |